Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.
作者信息
Klaassen D J, Boyes D A, Gerulath A, Levitt M, Miller A B, Pearson J G
出版信息
Cancer Treat Rep. 1979 Feb;63(2):289-95.
PMID:376135
Abstract
摘要
相似文献
1
Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.
Cancer Treat Rep. 1979 Feb;63(2):289-95.
2
Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.美法仑、5-氟尿嘧啶和甲氨蝶呤联合与序贯治疗晚期卵巢癌的比较
Can Med Assoc J. 1980 Sep 6;123(5):365-71.
3
4
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
N Engl J Med. 1978 Dec 7;299(23):1261-6. doi: 10.1056/NEJM197812072992301.
5
6
7
Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
Natl Cancer Inst Monogr. 1975 Oct;42:145-8.
8
Histologic grade in advanced ovarian cancer.
Cancer Treat Rep. 1979 Feb;63(2):255-63.
9
[Chemotherapy in curable breast cancer].[可治愈乳腺癌的化疗]
J Gynecol Obstet Biol Reprod (Paris). 1978 Mar;7(2):175-82.
10
[Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
Bull Cancer. 1982;69(5):426-33.
引用本文的文献
1
Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.美法仑、5-氟尿嘧啶和甲氨蝶呤联合与序贯治疗晚期卵巢癌的比较
Can Med Assoc J. 1980 Sep 6;123(5):365-71.
2
Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
Invest New Drugs. 1989 Jul;7(2-3):255-60. doi: 10.1007/BF00170870.
Zotero 插件